Soft Tissue Sarcoma
Treatment with eribulin mesylate significantly extended overall survival compared with dacarbazine in patients with advanced soft tissue sarcoma.
Most Popular Right Now
Cixutumumab Plus Temsirolimus Improves PFS and With Encouraging OS for Bone and Soft Tissue SarcomaBy Gary Schwartz, MD, from the Memorial Sloan-Kettering Cancer Center
Read more >>>